Increased levels of soluble fms-like tyrosine kinase-1 are associated with adverse outcomes in pregnant women with COVID-19.

J Torres-TorresS Espino-Y-SosaLiona Chiu Yee PoonJ M Solis-ParedesG Estrada-GutierrezA Espejel-NuñezA Juarez-ReyesA Etchegaray-SolanaY Alfonso-GuillenL Aguilar-AndradeJ A Hernández-PachecoJ R Villafan-BernalRaigam Jafet Martínez-Portilla

Published in: Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology (2021)

Keyphrases

tyrosine kinase
coronavirus disease
sars cov
epidermal growth factor receptor
pregnant women
respiratory syndrome coronavirus